Moreover, the CSF/serum ratio of NfL was positively correlated with the CSF/serum ratio of albumin in MS patients, whereas one would expect a negative association in the case of an enhanced NfL transfer in the presence of an increased blood-CSF barrier permeability. The gene discussed is NEFL; the disease is myeloid sarcoma.